Frontage Holdings Corporation (FGHQF)

OTCMKTS · Delayed Price · Currency is USD

0.1500

0.00 (0.00%)

At close: Jul 30, 2026

48.51% (1Y)

Market Cap	347.62M -14.7%
Revenue (ttm)	256.69M +0.7%
Net Income	6.79M +758.8%
EPS	0.00 +745.9%
Shares Out	n/a
PE Ratio	51.17
Forward PE	19.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130,000
Open	0.1500
Previous Close	n/a
Day's Range	0.1500 - 0.1500
52-Week Range	0.1100 - 0.1520
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Frontage Holdings

Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such a... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2001

Employees 1,523

Stock Exchange OTCMKTS

Ticker Symbol FGHQF

Financial Performance

In 2025, Frontage Holdings's revenue was $256.69 million, an increase of 0.70% compared to the previous year's $254.91 million. Earnings were $6.79 million, an increase of 758.79%.

Financial Statements